about
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and ...
Read More
4.41
0.06
(1.38%)
730.2K
XNAS Volume
XNAS 17 Sep, 2026 3:48 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Bullish
Momentum Trap
These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution
View Similar
Embed DVM
OmniAb Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..